Yervoy

Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer

Fierce Pharma

Sun, 04/13/25 - 11:19 pm

Bristol Myers Squibb

Opdivo

Yervoy

hepatocellular carcinoma

FDA

FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer

Cure Today

Tue, 04/8/25 - 10:49 pm

FDA looks at Opdivo/Yervoy in first-line colorectal cancer

Pharmaphorum

Mon, 02/24/25 - 09:56 am

Bristol Myers, Pfizer tout new standards of care in colorectal cancer subtypes

Fierce Pharma

Sun, 01/26/25 - 04:11 pm

FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds

Fierce Pharma

Fri, 08/23/24 - 10:55 am

BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer

Pharmaphorum

Thu, 08/22/24 - 11:09 am

ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer

Fierce Pharma

Tue, 06/4/24 - 11:52 am

ASCO: Bristol Myers unveils I-O triplet data in melanoma as Iovance touts ‘paradigm-changing’ combo result

Fierce Pharma

Thu, 05/23/24 - 09:46 pm

As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer

Fierce Pharma

Mon, 05/13/24 - 11:20 am

non-small cell lung cancer

AstraZeneca

Imfinzi

BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche

BioSpace

Wed, 03/20/24 - 11:51 am

BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer

BioSpace

Fri, 12/8/23 - 10:00 am

metastatic colorectal cancer

clinical trials

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

CP WIre

Sat, 03/18/23 - 03:37 pm

executive compensation

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Sat, 03/18/23 - 03:35 pm

executive compensation

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Tue, 01/24/23 - 06:31 pm

Regeneron's Libtayo posts lung cancer win with Bristol's Yervoy. But company won't seek approval

Fierce Pharma

Thu, 12/1/22 - 07:11 pm

Regeneron

Libtayo

non-small cell lung cancer

Bristol Myers Squibb

Yervoy

ESMO: Bristol Myers, Roche fail in post-surgery kidney cancer. But is it good news for Merck's Keytruda?

Fierce Pharma

Mon, 09/12/22 - 10:57 am

Exelixis trot out Opdivo-Yervoy-Cabometyx combo win in kidney cancer. Will FDA accept?

Fierce Pharma

Mon, 07/11/22 - 05:48 pm

ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy

Fierce Pharma

Thu, 09/16/21 - 10:56 am

Bristol Myers rolls out 3-year data mesothelioma data for Opdivo/Yervoy in first look at ESMO slate

Endpoints

Mon, 09/13/21 - 10:32 am

Search form

You are here

Yervoy

Pages